Clinical Patterns of Sarcoidosis Patients with and without Uveitis: Insights from a Dutch Sarcoidosis Centre

References

• Drent M, Costabel U, Crouser ED, Grunewald J, Bonella F. Misconceptions regarding symptoms of sarcoidosis. Lancet Respir Med. 2021;9(8):816–818. doi:10.1016/S2213-2600(21)00311-8.
   PubMed Web of Science ®Google Scholar
• Drent M, Crouser ED, Grunewald J. Challenges of sarcoidosis and its management. N Engl J Med. 2021;385(11):1018–1032. doi:10.1056/NEJMra2101555.
   PubMed Web of Science ®Google Scholar
• Arkema EV, Cozier YC. Sarcoidosis epidemiology: recent estimates of incidence, prevalence and risk factors. Curr Opin Pulm Med. 2020;26(5):527–534. doi:10.1097/MCP.0000000000000715.
   PubMed Web of Science ®Google Scholar
• Rothova A. Ocular involvement in sarcoidosis. Br J Ophthalmol. 2000;84(1):110–116. doi:10.1136/bjo.84.1.110.
   PubMed Web of Science ®Google Scholar
• Giorgiutti S, Jacquot R, El Jammal T, Bert A, Jamilloux Y, Kodjikian L, et al. Sarcoidosis-related uveitis: a review. J Clin Med. 2023;12(9):3194. doi:10.3390/jcm12093194.
   PubMed Web of Science ®Google Scholar
• El Jammal T, Loria O, Jamilloux Y, Gerfaud-Valentin M, Kodjikian L, Seve P. Uveitis as an open window to systemic inflammatory diseases. J Clin Med. 2021;10(2). doi:10.3390/jcm10020281.
   PubMed Web of Science ®Google Scholar
• James DG, Anderson R, Langley D, Ainslie D. Ocular sarcoidosis. Br J Ophthalmol. 1964;48(9):461–470. doi:10.1136/bjo.48.9.461.
   PubMedGoogle Scholar
• Karma A, Huhti E, Poukkula A. Course and outcome of ocular sarcoidosis. Am J Ophthalmol. 1988;106(4):467–472. doi:10.1016/0002-9394(88)90885-9.
   PubMed Web of Science ®Google Scholar
• Jabs DA, Johns CJ. Ocular involvement in chronic sarcoidosis. Am J Ophthalmol. 1986;102(3):297–301. doi:10.1016/0002-9394(86)90001-2.
   PubMed Web of Science ®Google Scholar
• Crick RP, Hoyle C, Smellie H. The eyes in sarcoidosis. Br J Ophthalmol. 1961;45(7):461–481. doi:10.1136/bjo.45.7.461.
   PubMedGoogle Scholar
• Pietinalho A, Ohmichi M, Hiraga Y, Lofroos AB, Selroos O. The mode of presentation of sarcoidosis in Finland and Hokkaido, Japan. A comparative analysis of 571 Finnish and 686 Japanese patients. Sarcoidosis Vasc Diffuse Lung Dis. 1996;13(2):159–166. doi:10.1007/BF00389839.
   Google Scholar
• Morimoto T, Azuma A, Abe S, Usuki J, Kudoh S, Sugisaki K, et al. Epidemiology of sarcoidosis in Japan. Eur Respir J. 2008;31(2):372–379. doi:10.1183/09031936.00075307.
   PubMed Web of Science ®Google Scholar
• Evans M, Sharma O, LaBree L, Smith RE, Rao NA. Differences in clinical findings between Caucasians and African Americans with biopsy-proven sarcoidosis. Ophthalmology. 2007;114(2):325–333. doi:10.1016/j.ophtha.2006.05.074.
   PubMed Web of Science ®Google Scholar
• Rothova A, Alberts C, Glasius E, Kijlstra A, Buitenhuis HJ, Breebaart AC. Risk factors for ocular sarcoidosis. Doc Ophthalmol. 1989;72(3–4):287–296. doi:10.1007/BF00153496.
   PubMed Web of Science ®Google Scholar
• Huang XF, Brown MA. Progress in the genetics of uveitis. Genes Immun. 2022;23(2):57–65. doi:10.1038/s41435-022-00168-6.
   PubMed Web of Science ®Google Scholar
• Wijnen PA, Nelemans PJ, Verschakelen JA, Bekers O, Voorter CE, Drent M. The role of tumor necrosis factor alpha G-308A polymorphisms in the course of pulmonary sarcoidosis. Tissue Antigens. 2010;75(3):262–268. doi:10.1111/j.1399-0039.2009.01437.x.
   PubMedGoogle Scholar
• Swider C, Schnittger L, Bogunia-Kubik K, Gerdes J, Flad H, Lange A, et al. TNF-alpha and HLA-DR genotyping as potential prognostic markers in pulmonary sarcoidosis. Eur Cytokine Netw. 1999;10(2):143–146.
   PubMed Web of Science ®Google Scholar
• Medica I, Kastrin A, Maver A, Peterlin B. Role of genetic polymorphisms in ACE and TNF-alpha gene in sarcoidosis: a meta-analysis. J Hum Genet. 2007;52(10):836–847. doi:10.1007/s10038-007-0185-7.
   PubMed Web of Science ®Google Scholar
• Wijnen PA, Voorter CE, Nelemans PJ, Verschakelen JA, Bekers O, Drent M. Butyrophilin-like 2 in pulmonary sarcoidosis: a factor for susceptibility and progression? Hum Immunol. 2011;72(4):342–347. doi:10.1016/j.humimm.2011.01.011.
   PubMed Web of Science ®Google Scholar
• Rybicki BA, Walewski JL, Maliarik MJ, Kian H, Iannuzzi MC, Group AR. The BTNL2 gene and sarcoidosis susceptibility in African Americans and Whites. Am J Hum Genet. 2005;77(3):491–499. doi:10.1086/444435.
   PubMed Web of Science ®Google Scholar
• Drent M. Sarcoidosis: benefits of a multidisciplinary approach. Eur J Intern Med. 2003;14(4):217–220. doi:10.1016/s0953-6205(03)00076-1.
   PubMedGoogle Scholar
• Statement on Sarcoidosis. Joint statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med. 1999;160(2):736–755. doi:10.1164/ajrccm.160.2.ats4-99.
   PubMedGoogle Scholar
• Crouser ED, Maier LA, Wilson KC, Bonham CA, Morgenthau AS, Patterson KC, et al. Diagnosis and detection of sarcoidosis. An official American thoracic society clinical practice guideline. Am J Respir Crit Care Med. 2020;201(8):e26–e51. doi:10.1164/rccm.202002-0251ST.
   PubMed Web of Science ®Google Scholar
• Jabs DA, Nussenblatt RB, Rosenbaum JT, Standardization of Uveitis NomenclatureWorking G. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol. 2005;140(3):509–516. doi:10.1016/j.ajo.2005.03.057.
   PubMed Web of Science ®Google Scholar
• Standardization of Uveitis Nomenclature Working G. Classification Criteria for sarcoidosis-associated uveitis. Am J Ophthalmol. 2021;228:220–230. doi:10.1016/j.ajo.2021.03.047.
   PubMed Web of Science ®Google Scholar
• Mochizuki M, Smith JR, Takase H, Kaburaki T, Acharya NR, Rao NA, et al. Revised criteria of International Workshop on Ocular Sarcoidosis (IWOS) for the diagnosis of ocular sarcoidosis. Br J Ophthalmol. 2019;103(10):1418–1422. doi:10.1136/bjophthalmol-2018-313356.
   PubMed Web of Science ®Google Scholar
• Dietmaier WWC, Sivasubramanian N. LightCycler PCR For the Polymorphisms -308 and -238 in the TNF Alpha Gene And for the TNFB1/B2 Polymorphisms in the LT Alpha Gene. RapidCycle Real-Time PCR – Methods and Applications Genetics and Oncology. Berlin: Springer-Verlag; 2002: 95–105.
   Google Scholar
• Voorter CE, Rozemuller EH, de Bruyn-Geraets D, van der Zwan AW, Tilanus MG, van den Berg-Loonen EM. Comparison of DRB sequence-based typing using different strategies. Tissue Antigens. 1997;49(5):471–476. doi:10.1111/j.1399-0039.1997.tb02781.x.
   PubMedGoogle Scholar
• Hwang DK, Sheu SJ. An update on the diagnosis and management of ocular sarcoidosis. Curr Opin Ophthalmol. 2020;31(6):521–531. doi:10.1097/ICU.0000000000000704.
   PubMed Web of Science ®Google Scholar
• Seve P, Jamilloux Y, Tilikete C, Gerfaud-Valentin M, Kodjikian L, El Jammal T. Ocular Sarcoidosis. Semin Respir Crit Care Med. 2020;41(5):673–688. doi:10.1055/s-0040-1710536.
   PubMedGoogle Scholar
• Baughman RP, Teirstein AS, Judson MA, Rossman MD, Yeager H Jr., Bresnitz EA, et al. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med. 2001;164(10 Pt 1):1885–1889. doi:10.1164/ajrccm.164.10.2104046.
   PubMed Web of Science ®Google Scholar
• Judson MA, Boan AD, Lackland DT. The clinical course of sarcoidosis: presentation, diagnosis, and treatment in a large white and black cohort in the United States. Sarcoidosis Vasc Diffuse Lung Dis. 2012;29(2):119–127.
   PubMed Web of Science ®Google Scholar
• Chung YM, Lin YC, Liu YT, Chang SC, Liu HN, Hsu WH. Uveitis with biopsy-proven sarcoidosis in Chinese–a study of 60 patients in a uveitis clinic over a period of 20 years. J Chin Med Assoc. 2007;70(11):492–496. doi:10.1016/S1726-4901(08)70047-9.
   PubMedGoogle Scholar
• Ungprasert P, Crowson CS, Matteson EL. Influence of gender on epidemiology and clinical manifestations of sarcoidosis: a population-based retrospective cohort study 1976-2013. Lung. 2017;195(1):87–91. doi:10.1007/s00408-016-9952-6.
   PubMed Web of Science ®Google Scholar
• Wilsher ML, Young LM, Hopkins R, Cornere M. Characteristics of sarcoidosis in Maori and Pacific Islanders. Respirology. 2017;22(2):360–363. doi:10.1111/resp.12917.
   PubMed Web of Science ®Google Scholar
• Wu JJ, Schiff KR. Sarcoidosis. Am Fam Physician. 2004;70(2):312–322.
   PubMed Web of Science ®Google Scholar
• Sen HN, Davis J, Ucar D, Fox A, Chan CC, Goldstein DA. Gender disparities in ocular inflammatory disorders. Curr Eye Res. 2015;40(2):146–161. doi:10.3109/02713683.2014.932388.
   PubMed Web of Science ®Google Scholar
• Tsirouki T, Dastiridou A, Symeonidis C, Tounakaki O, Brazitikou I, Kalogeropoulos C, et al. A focus on the epidemiology of uveitis. Ocul Immunol Inflamm. 2018;26(1):2–16. doi:10.1080/09273948.2016.1196713.
   PubMed Web of Science ®Google Scholar
• Takase H. Characteristics and management of ocular sarcoidosis. Immunol Med. 2022;45(1):12–21. doi:10.1080/25785826.2021.1940740.
   PubMedGoogle Scholar
• Lee JH, Han YE, Yang J, Kim HC, Lee J. Clinical manifestations and associated factors of uveitis in patients with pulmonary sarcoidosis: a case control study. Sci Rep. 2023;13(1):22380. doi:10.1038/s41598-023-49894-5.
   PubMed Web of Science ®Google Scholar
• Niederer RL, Sharief L, Tomkins-Netzer O, Lightman SL. Uveitis in sarcoidosis - clinical features and comparison with other non-infectious uveitis. Ocul Immunol Inflamm. 2023;31(2):367–373. doi:10.1080/09273948.2022.2032189.
   PubMed Web of Science ®Google Scholar
• Perez-Alvarez R, Brito-Zeron P, Kostov B, Feijoo-Masso C, Fraile G, Gomez-de-la-Torre R, et al. Systemic phenotype of sarcoidosis associated with radiological stages. Analysis of 1230 patients. Eur J Intern Med. 2019;69:77–85. doi:10.1016/j.ejim.2019.08.025.
   PubMed Web of Science ®Google Scholar
• Allegri P, Olivari S, Rissotto F, Rissotto R. Sarcoid uveitis: an intriguing challenger. Medicina (Kaunas). 2022;58(7). doi:10.3390/medicina58070898.
   PubMed Web of Science ®Google Scholar
• Zur Bonsen LS, Pohlmann D, Rubsam A, Pleyer U. Findings and graduation of sarcoidosis-related uveitis: a single-center study. Cells. 2021;11(1):89. doi:10.3390/cells11010089.
   PubMed Web of Science ®Google Scholar
• Sungur G, Hazirolan D, Bilgin G. Pattern of ocular findings in patients with biopsy-proven sarcoidosis in Turkey. Ocul Immunol Inflamm. 2013;21(6):455–461. doi:10.3109/09273948.2013.775311.
   PubMed Web of Science ®Google Scholar
• Reid G, Williams M, Compton M, Silvestri G, McAvoy C. Ocular sarcoidosis prevalence and clinical features in the Northern Ireland population. Eye (Lond). 2022;36(10):1918–1923. doi:10.1038/s41433-021-01770-0.
   PubMed Web of Science ®Google Scholar
• Erckens RJ, Mostard RL, Wijnen PA, Schouten JS, Drent M. Adalimumab successful in sarcoidosis patients with refractory chronic non-infectious uveitis. Graefes Arch Clin Exp Ophthalmol. 2012;250(5):713–720. doi:10.1007/s00417-011-1844-0.
   PubMed Web of Science ®Google Scholar
• Choi SY, Lee JH, Won JY, Shin JA, Park YH. Ocular manifestations of biopsy-proven pulmonary sarcoidosis in Korea. J Ophthalmol. 2018;2018:9308414. doi:10.1155/2018/9308414.
   PubMed Web of Science ®Google Scholar
• Rasmussen A, Dawkins BA, Li C, Pezant N, Levin AM, Rybicki BA, et al. Multiple correspondence analysis and HLA-associations of organ involvement in a large cohort of African-American and European-American patients with sarcoidosis. Lung. 2023;201(3):297–302. doi:10.1007/s00408-023-00626-6.
   PubMedGoogle Scholar
• Garman L, Pezant N, Pastori A, Savoy KA, Li C, Levin AM, et al. Genome-wide association study of ocular sarcoidosis confirms HLA associations and implicates barrier function and autoimmunity in African Americans. Ocul Immunol Inflamm. 2021;29(2):244–249. doi:10.1080/09273948.2019.1705985.
   PubMed Web of Science ®Google Scholar
• Wijnen PA, Cremers JP, Nelemans PJ, Erckens RJ, Hoitsma E, Jansen TL, et al. Association of the TNF-alpha G-308A polymorphism with TNF-inhibitor response in sarcoidosis. Eur Respir J. 2014;43(6):1730–1739. doi:10.1183/09031936.00169413.
   PubMed Web of Science ®Google Scholar
• Valentonyte R, Hampe J, Huse K, Rosenstiel P, Albrecht M, Stenzel A, et al. Sarcoidosis is associated with a truncating splice site mutation in BTNL2. Nat Genet. 2005;37(4):357–364. doi:10.1038/ng1519.
   PubMed Web of Science ®Google Scholar
• Coudurier M, Freymond N, Aissaoui S, Calender A, Pacheco Y, Devouassoux G. Homozygous variant rs2076530 of BTNL2 and familial sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2009;26(2):162–166.
   PubMed Web of Science ®Google Scholar
• Li Y, Wollnik B, Pabst S, Lennarz M, Rohmann E, Gillissen A, et al. BTNL2 gene variant and sarcoidosis. Thorax. 2006;61(3):273–274. doi:10.1136/thx.2005.056564.
   PubMed Web of Science ®Google Scholar
• Suzuki H, Ota M, Meguro A, Katsuyama Y, Kawagoe T, Ishihara M, et al. Genetic characterization and susceptibility for sarcoidosis in Japanese patients: risk factors of BTNL2 gene polymorphisms and HLA class II alleles. Invest Ophthalmol Vis Sci. 2012;53(11):7109–7115. doi:10.1167/iovs.12-10491.
   PubMed Web of Science ®Google Scholar
• Heiligenhaus A, Wefelmeyer D, Wefelmeyer E, Rosel M, Schrenk M. The eye as a common site for the early clinical manifestation of sarcoidosis. Ophthalmic Res. 2011;46(1):9–12. doi:10.1159/000321947.
   PubMed Web of Science ®Google Scholar
• Dammacco R, Biswas J, Kivela TT, Zito FA, Leone P, Mavilio A, et al. Ocular sarcoidosis: clinical experience and recent pathogenetic and therapeutic advancements. Int Ophthalmol. 2020;40(12):3453–3467. doi:10.1007/s10792-020-01531-0.
   PubMed Web of Science ®Google Scholar